Terms ending in 2030
Every in-force patent on Ucb Pharma S.A.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,044,061 | 8-Alkynylxanthines and Derivatives In force · High confidence | Rheinische Friedrich-Wilhelms-Universitaet Bonn | In force | High confidence | |
| US 8,460,712 | Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivate In force · Medium confidence | Ucb Biopharma SPRL | In force | Medium confidence | |
| US 9,476,081 | Method for Producing Protein In force · High confidence | Ucb Biopharma SPRL | In force | High confidence | |
| US 8,563,036 | Pharmaceutical Compositions Comprising Brivaracetam In force · High confidence | Ucb Biopharma SPRL | In force | High confidence | |
| US 9,428,570 | Antibody Molecules Having Specificity for Human OX40 In force · High confidence | Ucb Biopharma SPRL | In force | High confidence | |
| US 9,394,361 | Isolated DNA Sequences Encoding, and Methods for Making,antibody Molecules Having Binding Specificity for Human IL-13 In force · High confidence | Ucb Biopharma SPRL | In force | High confidence | |
| US 9,315,565 | Method for Producing Protein In force · High confidence | Ucb Biopharma SPRL | In force | High confidence | |
| US 10,729,653 | Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives In force · Medium confidence | Ucb Developed Brands SRL | In force | Medium confidence | |
| US 8,946,476 | Novel Process for the Preparation of Amino Acid Derivatives In force · High confidence | Ucb Pharma GmbH | In force | High confidence | |
| US D755,956 | Cassette Device for Administering Medication In force · High confidence | Ucb Pharma S.A. | In force | High confidence | |
| 11 more term ends in 2030 · Pro | |||||
10 of 21 patents shown. Soonest term end first, then patent number.
Pro members see all 21.
11 of these are in force and held by Ucb Pharma S.A..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.